论文部分内容阅读
目的：评价黛力新联合艾司唑仑治疗功能性消化不良的临床疗效。方法：将90例功能性消化不良患者随机分成 A、B、C 三组，A 组为对照组，予以莫沙必利5mgtid、兰索拉唑30mgqd，B 组在 A 组的基础上加用黛力新10mg 早、中午各一次口服，C 组在 B 组基础上针对有睡眠障碍，严重不安患者加用艾司唑仑1mg，睡前口服，三组疗程均为8周。结果：治疗组疗效明显优于对照组，P ＜0．01，差异有显著性。结论：黛力新联合艾司唑仑治疗功能性消化不良疗效显著。“,”Objective:To evaluate the ef icacy of Deanxit and Estazolam for functional dyspepsia.Method:90 patients are randomized to 3 groups(group A ,group B,group C)and re-ceive 8 weeks of medicine .Patients of group A receive mosapride in dose of 5mg(tid)and lansoprazole in dose of 30mg(qd).Patients of group B receive Deanxit in dose of 10mg(bid in morn-ing and noon)besides the dosage regimen of patients in group A.Patients in group C receive the same treatment with group B,and patients with sleep disorder or/and severe anxiety of group C receive estazolam in dose of 1mg(oral before sleeping).Results:The ef icacy of group B and C is significantly bet er than group A(P <0.01).Conculsion:the Combination Deanxit -Estazolam is a ef itive treatment for functional dyspepsia.